Capital Stock	3 Months Ended
Mar. 31, 2025
Equity [Abstract]
Capital Stock	11. CAPITAL STOCK As of March 31, 2025, the Company was authorized to issue 450,000,000 shares of common stock, $0.01 par value per share of which 11,338,391 were issued and outstanding. The Company was also authorized to issue 50,000,000 shares of preferred stock, $0.01 par value per share, of which none has been issued. On January 14, 2022, the Company entered into an At Market Offering Sales Agreement (the “Prior Sales Agreement”) with B. Riley Securities, Inc. (the “Prior Agent”) pursuant to which the Company may sell, from time to time, shares of common stock, par value $0.01 per share, having an aggregate offering price of up to $15,000,000, through the Prior Agent. There were no shares of common stock sold during the three months ended March 31, 2025 and 2024, under the Prior Sales Agreement.

Capital Stock

3 Months Ended

Mar. 31, 2025

11. CAPITAL STOCK

As of March 31, 2025, the Company was authorized to issue 450,000,000 shares of common stock, $0.01 par value per share of which 11,338,391 were issued and outstanding. The Company was also authorized to issue 50,000,000 shares of preferred stock, $0.01 par value per share, of which none has been issued.

On January 14, 2022, the Company entered into an At Market Offering Sales Agreement (the “Prior Sales Agreement”) with B. Riley Securities, Inc. (the “Prior Agent”) pursuant to which the Company may sell, from time to time, shares of common stock, par value $0.01 per share, having an aggregate offering price of up to $15,000,000, through the Prior Agent. There were no shares of common stock sold during the three months ended March 31, 2025 and 2024, under the Prior Sales Agreement.